Yang, K., He, Z. (2026). Fruquintinib combined with everolimus in Chinese patients with advanced/metastatic clear cell renal cell carcinoma (ccRCC) after progression on immune checkpoint inhibitors (ICIs): Results from a phase II single arm clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.497